Clearance Summary
PERRY(R) ENCORE CHEMOTHERAPY GLOVE received FDA 510(k) clearance under submission number K911633, sponsored by Smith & Nephew Perry. The device was reviewed via the Traditional premarket notification pathway and assigned to the General Hospital review panel. The statutory decision date of record is 1991-05-09.
- Submission: K911633
- Applicant / Sponsor: Smith & Nephew Perry
- Clearance pathway: Traditional
- Review panel: General Hospital
- Device class: Class I
- Regulation citation: 21 CFR 880.6250
- Decision date: 1991-05-09
Classification & Regulation
This clearance is catalogued under FDA product code LYY and 21 CFR 880.6250, within the General Hospital review panel as a Class I device.